Tag Archives: Hepatitis C

12.22.16

Obama signs $6.3 billion Cures Act – But Does it Do More Harm than Good?

By | Leave a Comment

On December 13th, President Obama signed the 21st Century Cures Act into law. This law provides $6.3 billion for cancer cure research, and to address the growing opioid drug abuse epidemic. The Act also allows for a more streamlined approval process for the FDA to bring new drugs and medical devices to the market. While […]

Posted in FDA, Health reform, uncategorized ; Tagged: , .

11.21.16

Now What?? The Potential Effects of a Trump Administration and Republican-Controlled Congress on Hepatitis C care

By | Leave a Comment

The 2016 presidential election ended in a result that few who are passionate about public health, human rights, and race, gender and sexual orientation equality could have ever wanted. However, as we face the reality of this reality, we who work to improve health outcomes must steel our resolve and continue to address the critical […]

Posted in Health reform, Healthcare ; Tagged: , .

09.29.16

O’Neill Institute Hosts Meeting to discuss improving Hepatitis C data collection and surveillance

By | Leave a Comment

On September 19th, the Hepatitis C Policy Project hosted a meeting at the Georgetown University Law Center in Washington, DC to discuss strategies to improve data collection and case surveillance for Hepatitis C in the United States. Thought leaders from a range of public health backgrounds, – including physicians, patient advocates, researchers and federal agency directors […]

Posted in Healthcare, uncategorized ; Tagged: , .

09.29.16

O'Neill Institute Hosts Meeting to discuss improving Hepatitis C data collection and surveillance

By | Leave a Comment

On September 19th, the Hepatitis C Policy Project hosted a meeting at the Georgetown University Law Center in Washington, DC to discuss strategies to improve data collection and case surveillance for Hepatitis C in the United States. Thought leaders from a range of public health backgrounds, – including physicians, patient advocates, researchers and federal agency directors […]

Posted in Healthcare, uncategorized ; Tagged: , .

05.05.16

May is National Hepatitis Awareness Month: Hepatitis C testing is critically important as CDC reports infection rates and deaths in U.S. at all-time high

By | Leave a Comment

May is National Hepatitis Awareness Month. The CDC has designated May 19th, 2016 as National Hepatitis Testing Day in the U.S. This campaign is particularly timely this year given the report released this Wednesday by the CDC  which states that new infections and deaths caused by Hepatitis C (HCV) are at the highest rates ever reported. […]

Posted in Health reform, Healthcare ; Tagged: , .

04.05.16

HHS guidance on syringe service programs provides substantive support for HCV and HIV infection reduction efforts among injection drug users.

By | Leave a Comment

On March 29, 2016, the Department of Health and Human Services released guidance to assist state and local health departments to request permission to use federal funds for Syringe Support Programs (SSPs). This guidance is in response to bipartisan legislation passed in December 2015 that relaxed previous restrictions on federal funds being used for any […]

Posted in Healthcare, Resources, uncategorized ; Tagged: , , , .

02.10.16

FY 2017 Federal budget proposal addresses Hepatitis C epidemic, but misses opportunity to reach many at highest risk for infection

By | Leave a Comment

  Yesterday the White House released the proposed budget for fiscal year 2017. It includes a $5 million funding increase to the CDC and a $9 million increase to HRSA to support viral hepatitis prevention and treatment initiatives, with an emphasis on addressing the Hepatitis C epidemic. The $5 million at CDC will fund increased efforts […]

Posted in Healthcare, uncategorized ; Tagged: , .

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.